- 1.
Zhou Y, Yang Q, Chi J et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis 2020; 99: 47–56. [PubMed][CrossRef]
- 2.
Garrison MM, Jeffries H, Christakis DA. Risk of death for children with down syndrome and sepsis. J Pediatr 2005; 147: 748–52. [PubMed][CrossRef]
- 3.
Bloemers BL, Broers CJ, Bont L et al. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect 2010; 12: 799–808. [PubMed][CrossRef]
- 4.
Englund A, Jonsson B, Zander CS et al. Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet A 2013; 161A: 642–9. [PubMed][CrossRef]
- 5.
Espinosa JM. Down syndrome and COVID-19: A perfect storm? Cell Rep Med 2020; 1: 100019. [PubMed][CrossRef]
- 6.
Laing AG, Lorenc A, Del Molino Del Barrio I et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med 2020; 9. doi: 10.1038/s41591-020-1038-6. [PubMed][CrossRef]
- 7.
Araya P, Waugh KA, Sullivan KD et al. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A 2019; 116: 24231–41. [PubMed][CrossRef]
- 8.
Waugh KA, Araya P, Pandey A et al. Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in down syndrome. Cell Rep 2019; 29: 1893–1908.e4. [PubMed][CrossRef]
- 9.
Broers CJ, Gemke RJ, Weijerman ME et al. Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus. J Clin Immunol 2012; 32: 323–9. [PubMed][CrossRef]
- 10.
Zhang Y, Che M, Yuan J et al. Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis. Oncotarget 2017; 8: 84489–96. [PubMed][CrossRef]
- 11.
Sullivan KD, Evans D, Pandey A et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep 2017; 7: 14818. [PubMed][CrossRef]
- 12.
Mazzotta F, Troccoli T, Caselli D et al. Acral rash in a child with COVID-1. Eur J Pediat Dermatol 2020; 30: 79–82.
- 13.
Ahmad K, Mazza A, Bonanomi E et al. COVID-19 and children with Down syndrome: Is there any real reason to worry? Case report. Research Square 2020 doi: 10.21203/rs.3.rs-44432/v1. [CrossRef]
- 14.
Krishnan US, Krishnan SS, Jain S et al. SARS-CoV-2 infection in patients with Down syndrome, congenital heart disease, and pulmonary hypertension: Is Down syndrome a risk factor? J Pediatr 2020; 225: 246–8. [PubMed][CrossRef]
- 15.
De Cauwer H, Spaepen A. Are patients with Down syndrome vulnerable to life-threatening COVID-19? Acta Neurol Belg 2020; 120: 1–3. [PubMed]
- 16.
Malle L, Gao C, Bouvier N et al. COVID-19 hospitalization is more frequent and severe in Down syndrome medRxiv 2020 doi: 10.1101/2020.05.26.20112748. [CrossRef]
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.
Downs syndrom og vaksine
09.04.2021Denne artikkelen er noen måneder gammel og jeg lurer på om det er nye erfaringer i forbindelse med vaksinering av personer med Downs syndrom? Jeg vil gjerne vite om nye erfaringer med denne risikogruppen.